Illness modeling requires applicable mobile fashions that finest mimic the underlying pathophysiology. Human origin and an ample expression of the illness protein are pre-requisites that assist info from a mannequin to be significant. On this research we investigated expression profiles of (i) PBMCs and (ii) fibroblasts as affected person derived cells in addition to (iii) lymphoblasts and (iv) induced pluripotent stem cells (iPSC) as immortalized sources, and (v) iPSC-derived cortical neurons to evaluate their aptitude to mannequin motor neuron illnesses (MNDs) together with hereditary spastic paraplegia (HSP), amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA).
We generated all 5 totally different cell sorts from two wholesome donors and carried out RNA sequencing to show expression patterns in MND-related genes. For the ten commonest HSP genotypes we validated gene expression by qPCR. To confirm the outcomes on protein stage, proteome evaluation of fibroblasts, iPSCs and cortical neurons was carried out. Relying on the particular MND gene we discovered largely totally different expression patterns. Out of 168 MND-related genes, 50 had their highest expression in iPSC-derived cortical neurons, 41 have been most strongly expressed in fibroblasts, 26 in lymphoblasts, 22 in iPSCs, and 14 in PBMCs.
Pathophysiologically associated MNDs like HSPs related to axonal transport deficits shared highest expression in cortical neurons. 15 MND-related genes weren’t detectable in any of the analyzed cell sorts. This may occasionally mirror the vital dependency of motor neurons on assist of different cell sorts like oligodendrocytes which specific myelin proteins like L1CAM (SPG1), PLP1 (SPG2) and MAG (SPG75) that are missing in neurons however trigger MNDs if mutated. This research gives complete info on expression of genes related to a big spectrum of MNDs. Expression profiles can be utilized to tell on applicable cell fashions for genotype particular motor neuron analysis.
A brand new standardized immunofluorescence methodology for efficiency quantification (SMPQ) of human conjunctival cell cultures
The intention of this research is to arrange a standardized and reproducible methodology to find out the efficiency (= stem cell content material) of human conjunctival cell cultures by the use of immunofluorescence-based analyses. This may assist the event of recent Superior Remedy Medicinal Merchandise (ATMPs) to make use of in future cell remedy medical research when fewer cells can be found to carry out the standard controls. To realize this goal, a reference normal was investigated and the expression ranges of ΔNp63α (thought-about as a marker of conjunctival stem cells) was correlated to cell dimension.
The limbal hTERT cells have been used as reference normal to outline the expression worth of ΔNp63α. The imply depth worth of limbal hTERT cells ranging between 15 and 20 µm in diameter was used to differentiate between ΔNp63α vivid and never vivid cells. As ΔNp63α vivid expression was primarily seen within the smaller cell dimension group (10-15 µm), we outlined as conjunctival stem cells (= efficiency) these cells which have been vivid and with sizes between 10 and 15 µm.
Assays on cells from clonal analyses have been used to validate the strategy, as they do enable to look at a lower in efficiency (Holoclones > Meroclones > Paraclones). The stem cell content material of conjunctival grafts was discovered to be 11.3% ± 5.Zero in comparison with 21.9% ± 0.6, 9.0% ± 8.1 and 0% from Holoclones, Meroclones and Paraclones, respectively. This new methodology, right here named as Standardized Technique for Efficiency Quantification, will enable to detect the efficiency in conjunctival cell cultures, thus acquiring a high quality management assay responding to the GMP requirements required for ATMP launch.
Launch from cell cycle arrest with Cdk4/6 inhibitors generates extremely synchronized cell cycle development in human cell tradition
Every method used to synchronize cell cycle development of human cell strains presents a singular set of challenges. Induction synchrony with brokers that transiently block development via key cell cycle phases are standard, however change stoichiometries of cell cycle regulators, invoke compensatory adjustments in progress fee and, for DNA replication inhibitors, injury DNA.
The manufacturing, substitute or manipulation of a goal molecule should be exceptionally fast if the interpretation of phenotypes within the cycle underneath research is to stay unbiased of impacts upon development via the previous cycle. We present how these challenges are averted by exploiting the flexibility of the Cdk4/6 inhibitors, palbociclib, ribociclib and abemaciclib to arrest cell cycle development on the pure management level for cell cycle dedication: the restriction level. After earlier work discovered no change within the coupling of progress and division throughout restoration from CDK4/6 inhibition, we discover excessive levels of synchrony in cell cycle development.
Though we validate CDK4/6 induction synchronization with hTERT-RPE-1, A549, THP1 and H1299, it’s efficient in different strains and avoids the DNA injury that accompanies synchronization by thymidine block/launch. Competence to return to cycle after 72 h arrest allows out of cycle goal induction/manipulation, with out impacting upon previous cycles.
Clofazimine is a broad-spectrum coronavirus inhibitor that antagonizes SARS-CoV-2 replication in major human cell tradition and hamsters
COVID-19 pandemic is the third zoonotic coronavirus (CoV) outbreak of the century after extreme acute respiratory syndrome (SARS) in 2003 and Center East respiratory syndrome (MERS) since 2012. Therapy choices for CoVs are largely missing. Right here, we present that clofazimine, an anti-leprosy drug with a positive security and pharmacokinetics profile, possesses pan-coronaviral inhibitory exercise, and might antagonize SARS-CoV-2 replication in a number of in vitro techniques, together with the human embryonic stem cell-derived cardiomyocytes and ex vivo lung cultures.
The FDA-approved molecule was discovered to inhibit a number of steps of viral replication, suggesting a number of underlying antiviral mechanisms. In a hamster mannequin of SARS-CoV-2 pathogenesis, prophylactic or therapeutic administration of clofazimine considerably lowered viral load within the lung and fecal viral shedding, and likewise prevented cytokine storm related to viral an infection.
 Megakaryocytes/platelets inducing agent |
|
MBS387689-10mg |
MyBiosource |
10mg |
EUR 1905 |
Megakaryocytes/platelets inducing agent |
|
MBS387689-1mg |
MyBiosource |
1mg |
EUR 430 |
Megakaryocytes/platelets inducing agent |
|
MBS387689-5mg |
MyBiosource |
5mg |
EUR 1165 |
Megakaryocytes/platelets inducing agent |
|
MBS387689-5x10mg |
MyBiosource |
5x10mg |
EUR 8565 |
 Serotonin ELISA kit Serum, Urine, Platelets |
|
BA-E-8900 |
ImmuSmol SAS |
1 kit |
EUR 343.44 |
|
Description: App. 1 year |
 Serotonin ELISA kit Serum, Urine, Platelets - Research |
|
BA-E-8900R |
ImmuSmol SAS |
1 kit |
EUR 343.44 |
|
Description: App. 1 year |
) Mixed Titer Bacteria Panel for Platelets (12 Samples 0.1 mL) |
|
0820000 |
Zeptometrix |
- |
EUR 488 |
Mixed Titer Bacteria Panel for Platelets (12 Samples 0.1 mL) |
|
820000 |
Zeptometrix |
12 Samples 0.1 mL |
EUR 488 |
-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 1) PLA2G2A (untagged)-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 1 |
|
SC119954 |
Origene Technologies GmbH |
10 µg |
Ask for price |
-Human phospholipase A2 group IIA (platelets synovial fluid) (PLA2G2A) transcript variant 2) PLA2G2A (untagged)-Human phospholipase A2 group IIA (platelets synovial fluid) (PLA2G2A) transcript variant 2 |
|
SC327372 |
Origene Technologies GmbH |
10 µg |
Ask for price |
-Human phospholipase A2 group IIA (platelets synovial fluid) (PLA2G2A) transcript variant 3) PLA2G2A (untagged)-Human phospholipase A2 group IIA (platelets synovial fluid) (PLA2G2A) transcript variant 3 |
|
SC327373 |
Origene Technologies GmbH |
10 µg |
Ask for price |
-Human phospholipase A2 group IIA (platelets synovial fluid) (PLA2G2A) transcript variant 4) PLA2G2A (untagged)-Human phospholipase A2 group IIA (platelets synovial fluid) (PLA2G2A) transcript variant 4 |
|
SC327374 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 - Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 1) PLA2G2A (GFP-tagged) - Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 1 |
|
RG203250 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 - Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 2) PLA2G2A (GFP-tagged) - Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 2 |
|
RG228737 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 - Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 3) PLA2G2A (GFP-tagged) - Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 3 |
|
RG228738 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 - Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 4) PLA2G2A (GFP-tagged) - Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 4 |
|
RG228739 |
Origene Technologies GmbH |
10 µg |
Ask for price |
-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 2) PLA2G2A (Myc-DDK-tagged)-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 2 |
|
RC228737 |
Origene Technologies GmbH |
10 µg |
Ask for price |
-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 3) PLA2G2A (Myc-DDK-tagged)-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 3 |
|
RC228738 |
Origene Technologies GmbH |
10 µg |
Ask for price |
-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 4) PLA2G2A (Myc-DDK-tagged)-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 4 |
|
RC228739 |
Origene Technologies GmbH |
10 µg |
Ask for price |
-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 1) PLA2G2A (Myc-DDK-tagged)-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 1 |
|
RC203250 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 (PLA2G2A), transcript variant 1, mGFP tagged) Lenti ORF clone of Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 1, mGFP tagged |
|
RC203250L2 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lenti ORF clone of Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 1, mGFP tagged |
|
RC203250L4 |
Origene Technologies GmbH |
10 µg |
Ask for price |
, partial) Recombinant Staphylococcus aureus Serine-rich adhesin for platelets (sasA), partial |
|
MBS1282410-005mgBaculovirus |
MyBiosource |
0.05mg(Baculovirus) |
EUR 1065 |
Recombinant Staphylococcus aureus Serine-rich adhesin for platelets (sasA), partial |
|
MBS1282410-005mgEColi |
MyBiosource |
0.05mg(E-Coli) |
EUR 735 |
Recombinant Staphylococcus aureus Serine-rich adhesin for platelets (sasA), partial |
|
MBS1282410-005mgYeast |
MyBiosource |
0.05mg(Yeast) |
EUR 900 |
Recombinant Staphylococcus aureus Serine-rich adhesin for platelets (sasA), partial |
|
MBS1282410-02mgYeast |
MyBiosource |
0.2mg(Yeast) |
EUR 1170 |
Recombinant Staphylococcus aureus Serine-rich adhesin for platelets (sasA), partial |
|
MBS1282410-05mgEColi |
MyBiosource |
0.5mg(E-Coli) |
EUR 1075 |
, partial) Recombinant Staphylococcus aureus Serine-rich adhesin for platelets (sraP), partial |
|
MBS1300560-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Staphylococcus aureus Serine-rich adhesin for platelets (sraP), partial |
|
MBS1291663-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Staphylococcus aureus Serine-rich adhesin for platelets (sraP), partial |
|
MBS1481773-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Staphylococcus aureus Serine-rich adhesin for platelets (sraP), partial |
|
MBS1408478-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Staphylococcus aureus Serine-rich adhesin for platelets (sraP), partial |
|
MBS1379960-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Staphylococcus aureus Serine-rich adhesin for platelets (sraP), partial |
|
MBS1442929-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Staphylococcus aureus Serine-rich adhesin for platelets (sraP), partial |
|
MBS1479116-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Staphylococcus aureus Serine-rich adhesin for platelets (sraP), partial |
|
MBS7096792-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
 (PLA2G2A), transcript variant 1, Myc-DDK-tagged) Lenti ORF clone of Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 1, Myc-DDK-tagged |
|
RC203250L1 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lenti ORF clone of Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 1, Myc-DDK-tagged |
|
RC203250L3 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 - Mouse phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), (10ug)) Pla2g2a (untagged) - Mouse phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), (10ug) |
|
MC202297 |
Origene Technologies GmbH |
10 µg |
Ask for price |
-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 2) Lenti-ORF clone of PLA2G2A (mGFP-tagged)-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 2 |
|
RC228737L4 |
Origene Technologies GmbH |
10 µg |
Ask for price |
-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 3) Lenti-ORF clone of PLA2G2A (mGFP-tagged)-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 3 |
|
RC228738L4 |
Origene Technologies GmbH |
10 µg |
Ask for price |
-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 4) Lenti-ORF clone of PLA2G2A (mGFP-tagged)-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 4 |
|
RC228739L4 |
Origene Technologies GmbH |
10 µg |
Ask for price |
-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 2, 200ul,) Lenti ORF particles, PLA2G2A (mGFP-tagged)-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 2, 200ul, |
|
RC228737L4V |
Origene Technologies GmbH |
200 µl |
Ask for price |
-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 3, 200ul,) Lenti ORF particles, PLA2G2A (mGFP-tagged)-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 3, 200ul, |
|
RC228738L4V |
Origene Technologies GmbH |
200 µl |
Ask for price |
-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 4, 200ul,) Lenti ORF particles, PLA2G2A (mGFP-tagged)-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 4, 200ul, |
|
RC228739L4V |
Origene Technologies GmbH |
200 µl |
Ask for price |
 - Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 1, 200ul) Lenti ORF particles, PLA2G2A (mGFP-tagged) - Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 1, 200ul |
|
RC203250L2V |
Origene Technologies GmbH |
200 µl |
Ask for price |
Lenti ORF particles, PLA2G2A (mGFP-tagged) - Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 1, 200ul |
|
RC203250L4V |
Origene Technologies GmbH |
200 µl |
Ask for price |
 - Rat phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), (10 ug)) Pla2g2a (untagged ORF) - Rat phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), (10 ug) |
|
RN211265 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 - Mouse phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a)) Pla2g2a (Myc-DDK-tagged) - Mouse phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a) |
|
MR200976 |
Origene Technologies GmbH |
10 µg |
Ask for price |
-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 2) Lenti-ORF clone of PLA2G2A (Myc-DDK-tagged)-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 2 |
|
RC228737L3 |
Origene Technologies GmbH |
10 µg |
Ask for price |
-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 2, 200u) Lenti ORF particles, PLA2G2A (Myc-DDK-tagged)-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 2, 200u |
|
RC228737L3V |
Origene Technologies GmbH |
200 µl |
Ask for price |
-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 3) Lenti-ORF clone of PLA2G2A (Myc-DDK-tagged)-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 3 |
|
RC228738L3 |
Origene Technologies GmbH |
10 µg |
Ask for price |
-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 3, 200u) Lenti ORF particles, PLA2G2A (Myc-DDK-tagged)-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 3, 200u |
|
RC228738L3V |
Origene Technologies GmbH |
200 µl |
Ask for price |
-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 4) Lenti-ORF clone of PLA2G2A (Myc-DDK-tagged)-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 4 |
|
RC228739L3 |
Origene Technologies GmbH |
10 µg |
Ask for price |
-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 4, 200u) Lenti ORF particles, PLA2G2A (Myc-DDK-tagged)-Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 4, 200u |
|
RC228739L3V |
Origene Technologies GmbH |
200 µl |
Ask for price |
 - Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 1, 20) Lenti ORF particles, PLA2G2A (Myc-DDK tagged) - Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 1, 20 |
|
RC203250L1V |
Origene Technologies GmbH |
200 µl |
Ask for price |
Lenti ORF particles, PLA2G2A (Myc-DDK tagged) - Human phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), transcript variant 1, 20 |
|
RC203250L3V |
Origene Technologies GmbH |
200 µl |
Ask for price |
 - Rat phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), (10 ug)) Pla2g2a (Myc-DDK-tagged ORF) - Rat phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), (10 ug) |
|
RR211265 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 - Mouse phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a)) Lenti ORF clone of Pla2g2a (mGFP-tagged) - Mouse phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a) |
|
MR200976L4 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 - Mouse phospholipase A2, group IIA (platelets, synovial fluid) (cDNA clone MGC:54610 IMAGE:6479080)) Pla2g2a (GFP-tagged) - Mouse phospholipase A2, group IIA (platelets, synovial fluid) (cDNA clone MGC:54610 IMAGE:6479080) |
|
MG200976 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 Human Soluble Platelet-Selectin ELISA Kit |
|
MBS011271-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Human Soluble Platelet-Selectin ELISA Kit |
|
MBS011271-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 550 |
Human Soluble Platelet-Selectin ELISA Kit |
|
MBS011271-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Human Soluble Platelet-Selectin ELISA Kit |
|
MBS011271-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 765 |
 - Mouse phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a)) Lenti ORF clone of Pla2g2a (Myc-DDK-tagged) - Mouse phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a) |
|
MR200976L3 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 - Rat phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), (10 ug)) Lenti ORF clone of Pla2g2a (mGFP-tagged ORF) - Rat phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), (10 ug) |
|
RR211265L4 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 - Rat phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), (10 ug)) Lenti ORF clone of Pla2g2a (Myc-DDK-tagged ORF) - Rat phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), (10 ug) |
|
RR211265L3 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 - Rat phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), 200ul, >10^7 TU/mL) Lenti ORF particles, Pla2g2a (GFP-tagged ORF) - Rat phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), 200ul, >10^7 TU/mL |
|
RR211265L4V |
Origene Technologies GmbH |
200 µl |
Ask for price |
 - Mouse phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), 200ul, >10^7 TU/mL) Lenti ORF particles, Pla2g2a (GFP-tagged) - Mouse phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), 200ul, >10^7 TU/mL |
|
MR200976L4V |
Origene Technologies GmbH |
200 µl |
Ask for price |
 Human soluble platelet-selectin,sP-selectin ELISA Kit |
|
201-12-0214 |
Shanghai Sunred Biological Technology |
96 tests |
EUR 528 |
|
|
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
ELISA Kit) Human soluble platelet-selectin(sP-selectin)ELISA Kit |
|
GA-E0230HM-48T |
GenAsia Biotech |
48T |
EUR 346.8 |
Human soluble platelet-selectin(sP-selectin)ELISA Kit |
|
GA-E0230HM-48Tests |
GenAsia Biotech |
48 Tests |
Ask for price |
Human soluble platelet-selectin(sP-selectin)ELISA Kit |
|
GA-E0230HM-96T |
GenAsia Biotech |
96T |
EUR 559.2 |
Human soluble platelet-selectin(sP-selectin)ELISA Kit |
|
GA-E0230HM-96Tests |
GenAsia Biotech |
96 Tests |
EUR 388 |
 Human soluble platelet-selectin, sP-selectin ELISA Kit |
|
MBS161073-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 3460 |
Human soluble platelet-selectin, sP-selectin ELISA Kit |
|
MBS161073-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 285 |
Human soluble platelet-selectin, sP-selectin ELISA Kit |
|
MBS161073-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 1750 |
Human soluble platelet-selectin, sP-selectin ELISA Kit |
|
MBS161073-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 425 |
Human soluble platelet-selectin,sP-selectin ELISA Kit |
|
YLA2129HU-48T |
Shanghai YL Biotech |
48T |
Ask for price |
Human soluble platelet-selectin,sP-selectin ELISA Kit |
|
YLA2129HU-96T |
Shanghai YL Biotech |
96T |
Ask for price |
 (PLA2G2A) transcript variant 3 for miRNA target validation) 3`UTR clone of phospholipase A2 group IIA (platelets synovial fluid) (PLA2G2A) transcript variant 3 for miRNA target validation |
|
SC203693 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 (PLA2G2A) transcript variant 2 for miRNA target validation) 3`UTR clone of phospholipase A2 group IIA (platelets synovial fluid) (PLA2G2A) transcript variant 2 for miRNA target validation |
|
SC203694 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 (PLA2G2A) transcript variant 4 for miRNA target validation) 3`UTR clone of phospholipase A2 group IIA (platelets synovial fluid) (PLA2G2A) transcript variant 4 for miRNA target validation |
|
SC203698 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 (PLA2G2A) transcript variant 1 for miRNA target validation) 3`UTR clone of phospholipase A2 group IIA (platelets synovial fluid) (PLA2G2A) transcript variant 1 for miRNA target validation |
|
SC203699 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 - Mouse phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), 200ul, >10^7 TU/mL) Lenti ORF particles, Pla2g2a (Myc-DDK-tagged) - Mouse phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), 200ul, >10^7 TU/mL |
|
MR200976L3V |
Origene Technologies GmbH |
200 µl |
Ask for price |
 - Rat phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), 200ul, >10^7 TU/mL) Lenti ORF particles, Pla2g2a (Myc-DDK-tagged ORF) - Rat phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), 200ul, >10^7 TU/mL |
|
RR211265L3V |
Origene Technologies GmbH |
200 µl |
Ask for price |
 Human soluble platelet-selectin-sP-selectin-ELISA Kit |
|
QY-E02476 |
Qayee Biotechnology |
96T |
EUR 450 |
) ARHGEF3, ID (ARHGEF3, Rho guanine nucleotide exchange factor 3, Exchange factor found in platelets and leukemic and neuronal tissues) |
|
MBS6008490-02mL |
MyBiosource |
0.2(mL |
EUR 695 |
ARHGEF3, ID (ARHGEF3, Rho guanine nucleotide exchange factor 3, Exchange factor found in platelets and leukemic and neuronal tissues) |
|
MBS6008490-5x02mL |
MyBiosource |
5x0.2mL |
EUR 2975 |
 (AP)) ARHGEF3, ID (ARHGEF3, Rho guanine nucleotide exchange factor 3, Exchange factor found in platelets and leukemic and neuronal tissues) (AP) |
|
MBS6274984-02mL |
MyBiosource |
0.2mL |
EUR 980 |
ARHGEF3, ID (ARHGEF3, Rho guanine nucleotide exchange factor 3, Exchange factor found in platelets and leukemic and neuronal tissues) (AP) |
|
MBS6274984-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
 (APC)) ARHGEF3, ID (ARHGEF3, Rho guanine nucleotide exchange factor 3, Exchange factor found in platelets and leukemic and neuronal tissues) (APC) |
|
MBS6274985-02mL |
MyBiosource |
0.2mL |
EUR 980 |
ARHGEF3, ID (ARHGEF3, Rho guanine nucleotide exchange factor 3, Exchange factor found in platelets and leukemic and neuronal tissues) (APC) |
|
MBS6274985-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
 (FITC)) ARHGEF3, ID (ARHGEF3, Rho guanine nucleotide exchange factor 3, Exchange factor found in platelets and leukemic and neuronal tissues) (FITC) |
|
MBS6274987-02mL |
MyBiosource |
0.2mL |
EUR 980 |
ARHGEF3, ID (ARHGEF3, Rho guanine nucleotide exchange factor 3, Exchange factor found in platelets and leukemic and neuronal tissues) (FITC) |
|
MBS6274987-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
 (PE)) ARHGEF3, ID (ARHGEF3, Rho guanine nucleotide exchange factor 3, Exchange factor found in platelets and leukemic and neuronal tissues) (PE) |
|
MBS6274994-02mL |
MyBiosource |
0.2mL |
EUR 980 |
ARHGEF3, ID (ARHGEF3, Rho guanine nucleotide exchange factor 3, Exchange factor found in platelets and leukemic and neuronal tissues) (PE) |
|
MBS6274994-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
 (Biotin)) ARHGEF3, ID (ARHGEF3, Rho guanine nucleotide exchange factor 3, Exchange factor found in platelets and leukemic and neuronal tissues) (Biotin) |
|
MBS6274986-02mL |
MyBiosource |
0.2mL |
EUR 980 |
ARHGEF3, ID (ARHGEF3, Rho guanine nucleotide exchange factor 3, Exchange factor found in platelets and leukemic and neuronal tissues) (Biotin) |
|
MBS6274986-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
 (MaxLight 405)) ARHGEF3, ID (ARHGEF3, Rho guanine nucleotide exchange factor 3, Exchange factor found in platelets and leukemic and neuronal tissues) (MaxLight 405) |
|
MBS6274989-01mL |
MyBiosource |
0.1mL |
EUR 980 |
ARHGEF3, ID (ARHGEF3, Rho guanine nucleotide exchange factor 3, Exchange factor found in platelets and leukemic and neuronal tissues) (MaxLight 405) |
|
MBS6274989-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4250 |
 (MaxLight 490)) ARHGEF3, ID (ARHGEF3, Rho guanine nucleotide exchange factor 3, Exchange factor found in platelets and leukemic and neuronal tissues) (MaxLight 490) |
|
MBS6274990-01mL |
MyBiosource |
0.1mL |
EUR 980 |
ARHGEF3, ID (ARHGEF3, Rho guanine nucleotide exchange factor 3, Exchange factor found in platelets and leukemic and neuronal tissues) (MaxLight 490) |
|
MBS6274990-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4250 |
 (MaxLight 550)) ARHGEF3, ID (ARHGEF3, Rho guanine nucleotide exchange factor 3, Exchange factor found in platelets and leukemic and neuronal tissues) (MaxLight 550) |
|
MBS6274991-01mL |
MyBiosource |
0.1mL |
EUR 980 |
ARHGEF3, ID (ARHGEF3, Rho guanine nucleotide exchange factor 3, Exchange factor found in platelets and leukemic and neuronal tissues) (MaxLight 550) |
|
MBS6274991-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4250 |
 (MaxLight 650)) ARHGEF3, ID (ARHGEF3, Rho guanine nucleotide exchange factor 3, Exchange factor found in platelets and leukemic and neuronal tissues) (MaxLight 650) |
|
MBS6274992-01mL |
MyBiosource |
0.1mL |
EUR 980 |
ARHGEF3, ID (ARHGEF3, Rho guanine nucleotide exchange factor 3, Exchange factor found in platelets and leukemic and neuronal tissues) (MaxLight 650) |
|
MBS6274992-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4250 |
 (MaxLight 750)) ARHGEF3, ID (ARHGEF3, Rho guanine nucleotide exchange factor 3, Exchange factor found in platelets and leukemic and neuronal tissues) (MaxLight 750) |
|
MBS6274993-01mL |
MyBiosource |
0.1mL |
EUR 980 |
ARHGEF3, ID (ARHGEF3, Rho guanine nucleotide exchange factor 3, Exchange factor found in platelets and leukemic and neuronal tissues) (MaxLight 750) |
|
MBS6274993-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4250 |
 (Azide free) (HRP)) ARHGEF3, ID (ARHGEF3, Rho guanine nucleotide exchange factor 3, Exchange factor found in platelets and leukemic and neuronal tissues) (Azide free) (HRP) |
|
MBS6274988-02mL |
MyBiosource |
0.2mL |
EUR 980 |
ARHGEF3, ID (ARHGEF3, Rho guanine nucleotide exchange factor 3, Exchange factor found in platelets and leukemic and neuronal tissues) (Azide free) (HRP) |
|
MBS6274988-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
 Human Platelet Lysate |
|
abx810372-10nmol |
Abbexa |
10 nmol |
EUR 3250 |
Human Platelet Lysate |
|
abx810372-5nmol |
Abbexa |
5 nmol |
EUR 1000 |
 Human platelet lysate |
|
FBS.PL.020 |
Bio&SELL |
20 mL |
Ask for price |
Human platelet lysate |
|
FBS.PL.100 |
Bio&SELL |
100 mL |
Ask for price |
 Human Platelet Factor 4 |
|
MBS135676-01mg |
MyBiosource |
0.1mg |
EUR 455 |
Human Platelet Factor 4 |
|
MBS135676-05mg |
MyBiosource |
0.5mg |
EUR 1405 |
Human Platelet Factor 4 |
|
MBS135676-1mg |
MyBiosource |
1mg |
EUR 2690 |
Human Platelet Factor 4 |
|
MBS135676-5x1mg |
MyBiosource |
5x1mg |
EUR 11875 |
Human Platelet Factor 4 |
|
GWB-ECA169 |
GenWay Biotech |
0.1 mg |
Ask for price |
 (human)) Platelet Factor 4 (58-70) (human) |
|
5-01776 |
CHI Scientific |
4 x 5mg |
EUR 294.84 |
|
Description: Pro-Leu-Tyr-Lys-Lys-Ile-Ile-Lys-Lys-Leu-Leu-Glu-Ser |
Platelet Factor 4 (58-70) (human) |
|
H-1174.0001 |
Bachem |
1.0mg |
EUR 138 |
|
Description: Sum Formula: C76H133N17O18; CAS# [82989-21-7] |
Platelet Factor 4 (58-70) (human) |
|
H-1174.0005 |
Bachem |
5.0mg |
EUR 441.6 |
|
Description: Sum Formula: C76H133N17O18; CAS# [82989-21-7] |
, human) Platelet Factor 4 (58-70), human |
|
MBS5763740-1mg |
MyBiosource |
1mg |
EUR 165 |
Platelet Factor 4 (58-70), human |
|
MBS5763740-5mg |
MyBiosource |
5mg |
EUR 260 |
Platelet Factor 4 (58-70), human |
|
MBS5763740-5x5mg |
MyBiosource |
5x5mg |
EUR 1015 |
Platelet Factor 4 (58-70) (human) |
|
MBS659778-5mg |
MyBiosource |
5mg |
EUR 380 |
Platelet Factor 4 (58-70) (human) |
|
MBS659778-5x5mg |
MyBiosource |
5x5mg |
EUR 1560 |
 (Human)) Platelet Factor 4 (58-70) (Human) |
|
MBS8246938-10mg |
MyBiosource |
10mg |
EUR 495 |
Platelet Factor 4 (58-70) (Human) |
|
MBS8246938-1mg |
MyBiosource |
1mg |
EUR 210 |
Platelet Factor 4 (58-70) (Human) |
|
MBS8246938-5mg |
MyBiosource |
5mg |
EUR 355 |
Platelet Factor 4 (58-70) (Human) |
|
MBS8246938-5x10mg |
MyBiosource |
5x10mg |
EUR 2150 |
Platelet Factor 4 (58-70), human |
|
TP1667-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
|
|
Description: Platelet Factor 4 (58-70), human |
Platelet Factor 4 (58-70), human |
|
TP1667-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
|
|
Description: Platelet Factor 4 (58-70), human |
Platelet Factor 4 (58-70), human |
|
TP1667-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
|
|
Description: Platelet Factor 4 (58-70), human |
Platelet Factor 4 (58-70), human |
|
TP1667-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
|
|
Description: Platelet Factor 4 (58-70), human |
Platelet Factor 4 (58-70), human |
|
TP1667-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
|
|
Description: Platelet Factor 4 (58-70), human |
) Human Platelet Factor-4 (CXCL4) |
|
7-02068 |
CHI Scientific |
5µg |
Ask for price |
Human Platelet Factor-4 (CXCL4) |
|
7-02069 |
CHI Scientific |
20µg |
Ask for price |
Human Platelet Factor-4 (CXCL4) |
|
7-02070 |
CHI Scientific |
1mg |
Ask for price |
Human Platelet Factor-4 (CXCL4) |
|
MBS143174-0005mg |
MyBiosource |
0.005mg |
EUR 240 |
Human Platelet Factor-4 (CXCL4) |
|
MBS143174-002mg |
MyBiosource |
0.02mg |
EUR 310 |
Human Platelet Factor-4 (CXCL4) |
|
MBS143174-1mg |
MyBiosource |
1mg |
EUR 3025 |
Human Platelet Factor-4 (CXCL4) |
|
MBS143174-5x1mg |
MyBiosource |
5x1mg |
EUR 13275 |
 Human Platelet Factor 4 CLIA Kit |
|
MBS8425814-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
) Platelet Factor 4, Human (PF4) |
|
MBS634642-01mg |
MyBiosource |
0.1mg |
EUR 725 |
Platelet Factor 4, Human (PF4) |
|
MBS634642-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3035 |
Platelet Factor 4, Human (PF4) |
|
MBS634666-01mg |
MyBiosource |
0.1mg |
EUR 540 |
Platelet Factor 4, Human (PF4) |
|
MBS634666-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2275 |
 – human) Platelet Factor 4 (PF4) – human |
|
PF4-h-02 |
Biometec GmbH |
200 µg |
EUR 561 |
|
|
Platelet Factor 4 (PF4) – human |
|
PF4-h-1 |
Biometec GmbH |
1mg |
EUR 1430 |
|
|
 Human Platelet Factor IV Protein |
|
abx060921-100ug |
Abbexa |
100 ug |
EUR 811.2 |
|
|
 Human Platelet Factor 4 ELISA kit |
|
E01A6889 |
BlueGene |
96T |
EUR 700 |
|
Description: ELISA |
 Human Platelet factor 3 ELISA kit |
|
E01A7053 |
BlueGene |
96T |
EUR 700 |
|
Description: ELISA |
 Human Platelet Factor 4 ELISA Kit |
|
MBS008893-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Human Platelet Factor 4 ELISA Kit |
|
MBS008893-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 550 |
Human Platelet Factor 4 ELISA Kit |
|
MBS008893-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Human Platelet Factor 4 ELISA Kit |
|
MBS008893-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 765 |
 Human Platelet Factor 3 ELISA Kit |
|
MBS038632-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Human Platelet Factor 3 ELISA Kit |
|
MBS038632-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 550 |
Human Platelet Factor 3 ELISA Kit |
|
MBS038632-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Human Platelet Factor 3 ELISA Kit |
|
MBS038632-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 765 |
Human Platelet Factor 4 ELISA kit |
|
E01P0085-192T |
BlueGene |
192 tests |
EUR 1524 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Human Platelet Factor 4 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Platelet Factor 4 ELISA kit |
|
E01P0085-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Human Platelet Factor 4 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Platelet Factor 4 ELISA kit |
|
E01P0085-48wellsplate |
BlueGene |
48 wells plate |
EUR 280 |
Human Platelet Factor 4 ELISA kit |
|
E01P0085-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Human Platelet Factor 4 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Platelet Factor 4 ELISA kit |
|
E01P0085-96wellsplate |
BlueGene |
96 wells plate |
EUR 405 |
Human Platelet factor 3 ELISA kit |
|
E01P0639-192T |
BlueGene |
192 tests |
EUR 1524 |
|
|
|
Description: A sandwich ELISA for quantitative measurement of Human Platelet factor 3 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Platelet factor 3 ELISA kit |
|
E01P0639-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
|
|
Description: A sandwich ELISA for quantitative measurement of Human Platelet factor 3 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Moreover, clofazimine exhibited synergy when administered with remdesivir. Since clofazimine is orally bioavailable and has a relatively low manufacturing value, it’s a horny medical candidate for outpatient therapy and remdesivir-based combinatorial remedy for hospitalized COVID-19 sufferers, notably in growing nations. Taken collectively, our information present proof that clofazimine might have a task within the management of the present pandemic SARS-CoV-2, endemic MERS-CoV within the Center East, and, probably most significantly, rising CoVs of the long run.
